HTLV-1 associated myelopathy in Canada.

HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

Detaylı Bibliyografya
Asıl Yazarlar:	Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1989

Benzer Materyaller

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY
Yazar:: Rice, G, ve diğerleri
Baskı/Yayın Bilgisi: (1986)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
Yazar:: Rice, G, ve diğerleri
Baskı/Yayın Bilgisi: (1986)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
Yazar:: Kevin G Buell, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Yazar:: Kirk, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.
Yazar:: Felipe von Glehn, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy
Yazar:: Tomoo Sato, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy
Yazar:: Aowei Lv, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
Yazar:: Antonio Mastino, ve diğerleri
Baskı/Yayın Bilgisi: (2011-05-01)

Magnetic resonance imaging in HTLV-I associated myelopathy
Yazar:: Aílton Melo, ve diğerleri
Baskı/Yayın Bilgisi: (1993-09-01)

HTLV-I associated myelopathy in salvador (northeastern Brazil)
Yazar:: A. Meireles, ve diğerleri
Baskı/Yayın Bilgisi: (1992-06-01)

Galvanic vestibular stimulation for the postural rehabilitation of HTLV-1-associated myelopathy
Yazar:: Tatiana Rocha Silva, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Yazar:: Alvaro Schwalb, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
Yazar:: Sheila N. F. Liberato de Matos, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Yazar:: Reza Boostani, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
Yazar:: Naiane Araújo Patrício, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Systemic interferon alfa in multiple sclerosis.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1989)

The natural history of multiple sclerosis.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
Yazar:: Satoshi Nozuma, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

An open trial of OKT3 in patients with multiple sclerosis.
Yazar:: Weinshenker, BG, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Yazar:: Jeffery, K, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Immunologic parameters of cerebrospinal fluid in HTLV-I associated myelopathy
Yazar:: Marzia Puccioni-sohler
Baskı/Yayın Bilgisi: (1995-06-01)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
Yazar:: Taylor Graham P, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
Yazar:: Stumpf Michael PH, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Yazar:: Satoshi Nozuma, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers
Yazar:: Ana Paula Silva Champs, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
Yazar:: Antonio C. R. Vallinoto, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
Yazar:: Akihito Koseki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients
Yazar:: Rosa Maria do Nascimento Marcusso, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Yazar:: Marco Baratella, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Yazar:: Yoshimi Enose-Akahata, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Overlapping Ossification of the Ligamentum Flavum
Yazar:: Guilherme Gago, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
Yazar:: Reza Boostani, ve diğerleri
Baskı/Yayın Bilgisi: (2016-05-01)

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará
Yazar:: Lucinda A. Souza, ve diğerleri
Baskı/Yayın Bilgisi: (2006-10-01)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
Yazar:: Houshang Rafatpanah, ve diğerleri
Baskı/Yayın Bilgisi: (2013-03-01)

Use of Oral Corticosteroids to Treat HTLV-1-Associated Myelopathy (HAM) in São Paulo, Brazil
Yazar:: Flavia Esper Dahy, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
Yazar:: Larissa Deadame de Figueiredo Nicolete, ve diğerleri
Baskı/Yayın Bilgisi: (2012-09-01)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
Yazar:: Shuntaro Tsutsumi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)